(Q45144735)

English

Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer

scientific article published in January 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

author name string

M Shibata

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

M Takekawa

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

S Amano

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

884-888

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Metabolic approaches to cancer cachexia

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Nutrition and cancer: physiological interrelationships

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Cancer cachexia and its nutritional implications

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

The role of tumor necrosis factor (cachectin) in cachexia

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor).

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Two TNF receptors

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Shedding of tumor necrosis factor receptors by activated human neutrophils

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Human TNF mutants with selective activity on the p55 receptor.

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Weight loss in patients with hematological neoplasias is associated with immune system stimulation

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Gamma-interferon: the match that lights the fire?

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells

1 reference

https://api.crossref.org/works/10.1007%2FS005950050247

21 January 2018

Increased level of soluble interleukin-2 receptor in advanced solid tumors: a preliminary study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexia

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of antitumor surgery on soluble interleukin-2 receptor serum levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and characterization of a tumor necrosis factor binding protein from urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble tumour necrosis factor receptors as prognostic factors in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer cachexia

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dominance of resistance to the cytocidal effect of tumor necrosis factor in heterokaryons formed by fusion of resistant and sensitive cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9744395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S005950050247

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

release_7pmr7wttrvb4bhlbxbksdmozoe

1 reference

https://api.fatcat.wiki/v0/release/7pmr7wttrvb4bhlbxbksdmozoe

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45144735&oldid=2067004575"